創薬における生成人工知能（AI）の世界市場レポート 2025年

創薬における生成人工知能（AI）市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR30.6％で7億4,000万米ドルに成長します。予測期間の成長は、費用対効果の高い創薬への需要が生成AIの採用を促進し、市場関係者間の協力関係の拡大、計算能力の向上、生成AIと他の新興技術との統合、迅速な医薬品開発に起因すると考えられます。予測期間における主要動向には、先進技術、実験生物学と生成AIの統合、創薬パイプラインを加速する高性能スクリーニング、薬剤再利用のためのAI主導型プラットフォームの開発、共同創薬活動のためのクラウドベースのAIソリューションの採用増加などが含まれます。

臨床検査の増加は、創薬市場における生成AIの拡大を促進すると予想されます。臨床検査とは、新しい治療法や処置の安全性と有効性を評価するために、ヒトのボランティアに対して検査を行うことであり、ヒトへの使用の適合性に関する科学的データを収集することを目的としています。臨床検査の増加は、医療研究の進歩、疾病負担の増加、規制の変更、臨床研究のグローバリゼーション、患者擁護と意識の向上、産業の競合、技術革新、資金調達の増加など、いくつかの要因に起因します。臨床検査からのデータは、相互作用の予測や化合物の設計によって創薬を加速させる生成AIモデルを強化します。この連携により、個別化医療が可能になり、治療効果が最適化され、患者の転帰が向上し、製薬産業が変革されます。例えば、2023年11月、英国を拠点とする産業団体である英国製薬工業協会（Association of the British Pharmaceutical Industry）は、英国で開始された臨床検査の年間件数が2021年の394件から2022年には411件へと4.3％増加したと報告しました。したがって、臨床検査数の増加が創薬市場における生成AIの成長を促進しています。

生成AI創薬市場の主要参入企業は、医薬品開発プロセスを迅速化するための洗練されたAI搭載ツールを開発しています。これらのツールはAIと機械学習を活用し、予測分析を通じて創薬、設計、臨床検査を効率化します。これらのツールは、標的同定、化合物スクリーニング、前臨床開発、規制遵守、製造の効率を高めています。例えば2023年5月、Google Cloudは2つの画期的なAI主導型ソリューション、Target and Lead Identification SuiteとMultiomics Suiteを発表しました。これらのソリューションは、創薬と精密医療を改善することで、バイオテクノロジー、製薬、公共部門の組織を支援します。Target and Lead Identification Suiteは、研究者がアミノ酸の機能を理解し、タンパク質の構造を予測するのを支援し、Multiomics Suiteはゲノムデータの分析を加速し、個別化治療の開発を促進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の創薬における生成人工知能（AI） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の創薬における生成人工知能（AI）市場：成長率分析
• 世界の創薬における生成人工知能（AI）市場の実績：規模と成長、2019～2024年
• 世界の創薬における生成人工知能（AI）市場の予測：規模と成長、2024～2029年、2034年
• 世界の創薬における生成人工知能（AI）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の創薬における生成人工知能（AI）市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 小分子
• 巨大分子
• 世界の創薬における生成人工知能（AI）市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• ディープラーニング
• 機械学習
• 強化学習
• 分子ドッキング
• 量子コンピューティング
• 世界の創薬における生成人工知能（AI）市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 製薬とバイオテクノロジー企業
• 学術研究機関
• 契約研究機関（CRO）
• その他
• 世界の創薬における生成人工知能（AI）市場、小分子のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 医薬品の設計と最適化
• リード発見と特定
• 毒性予測
• 分子特性予測
• ADMET（吸収、流通、代謝、排泄、毒性）予測
• 世界の創薬における生成人工知能（AI）市場、巨大分子のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• タンパク質構造予測
• 抗体設計
• 生物製剤の最適化
• ペプチド設計
• バイオ医薬品の発見と最適化

第7章 地域別・国別分析

• 世界の創薬における生成人工知能（AI）市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の創薬における生成人工知能（AI）市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 創薬における生成人工知能（AI）市場：競合情勢
• 創薬における生成人工知能（AI）市場：企業プロファイル
  • Bayer AG
  • NVIDIA Corporation
  • Merck KGaA
  • IBM Research
  • Schrodinger Inc.

第31章 その他の大手企業と革新的企業

• Valo Health
• BenevolentAI
• XtalPi Inc.
• Insilico Medicine Inc.
• Recursion Pharmaceuticals Inc.
• Exscientia
• Atomwise Inc.
• InveniAI LLC
• Healx
• Aitia
• Cloud Pharmaceuticals Inc.
• Optibrium
• Aiforia
• BioSymetrics Inc.
• Collaborations Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 創薬における生成人工知能（AI）市場、2029年：新たな機会を提供する国
• 創薬における生成人工知能（AI）市場、2029年：新たな機会を提供するセグメント
• 創薬における生成人工知能（AI）市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Generative AI in drug discovery utilizes advanced machine learning techniques, particularly generative models, to create and identify new pharmaceutical compounds. These AI systems analyze vast datasets encompassing chemical properties, biological activity, and existing drug information to predict and generate novel molecules with potential therapeutic benefits. The primary goal is to expedite the discovery of novel pharmaceutical compounds with therapeutic potential, streamlining the drug development process by leveraging extensive data to efficiently predict and generate new molecules.

The main types of generative artificial intelligence (AI) in drug discovery are small molecule and large molecule. Small molecules are chemically synthesized drugs with typically low molecular weights. Various technologies including deep learning, machine learning, reinforcement learning, molecular docking, and quantum computing are employed by a range of end-users, including pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations (CROs), and others.

The generative artificial intelligence (AI) in drug discovery market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in drug discovery market statistics, including generative artificial intelligence (AI) in drug discovery industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in drug discovery market share, detailed generative artificial intelligence (AI) in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in drug discovery industry. This generative artificial intelligence (AI) in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative artificial intelligence (AI) in drug discovery market size has grown exponentially in recent years. It will grow from $0.19 billion in 2024 to $0.25 billion in 2025 at a compound annual growth rate (CAGR) of 30.9%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, development of new drug discoveries and clinical trials, supporting AI integration into healthcare and drug development, growing biotech industries and increasing governmental support.

The generative artificial intelligence (AI) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to $0.74 billion in 2029 at a compound annual growth rate (CAGR) of 30.6%. The growth in the forecast period can be attributed to demand for cost-effective drug discovery drives adoption of generative AI, growing collaborations among market players, increasing computational power, integration of generative AI with other emerging technologies and rapid drug development. Major trends in the forecast period include advanced technologies, integration of generative AI with experimental biology, high-throughput screening for accelerated drug discovery pipelines, development of AI-driven platforms for drug repurposing and rising adoption of cloud-based AI solutions for collaborative drug discovery efforts.

The growing number of clinical trials is expected to drive the expansion of generative AI in the drug discovery market. Clinical trials involve testing new medical treatments or procedures on human volunteers to assess their safety and effectiveness, with the goal of collecting scientific data on their suitability for human use. The increase in clinical trials can be attributed to several factors, including advancements in medical research, a rising disease burden, regulatory changes, the globalization of clinical research, greater patient advocacy and awareness, industry competition, technological innovations, and increased funding. Data from clinical trials enhances generative AI models, which accelerate drug discovery by predicting interactions and designing compounds. This collaboration enables personalized medicine, optimizes treatment effectiveness, enhances patient outcomes, and transforms the pharmaceutical industry. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the annual number of clinical trials launched in the UK rose by 4.3%, from 394 trials in 2021 to 411 in 2022. Therefore, the increasing number of clinical trials is driving the growth of generative AI in the drug discovery market.

Key players in the generative AI drug discovery market are developing sophisticated AI-powered tools to expedite drug development processes. These tools leverage AI and machine learning to streamline drug discovery, design, and clinical trials through predictive analytics. They enhance efficiency in target identification, compound screening, preclinical development, regulatory compliance, and manufacturing. For instance, in May 2023, Google Cloud introduced two groundbreaking AI-driven solutions, the Target and Lead Identification Suite and the Multiomics Suite. These solutions empower biotech, pharmaceutical, and public sector organizations by improving drug discovery and precision medicine. The Target and Lead Identification Suite aids researchers in understanding amino acid functions and predicting protein structures, while the Multiomics Suite accelerates genomic data analysis, facilitating the development of personalized treatments.

In May 2023, Recursion Pharmaceuticals acquired Cyclica and Valence for $40 million and $47.5 million, respectively, bolstering its drug discovery capabilities through advanced technologies. These acquisitions position Recursion as a prominent hub for top-tier professionals in machine learning and AI, poised to innovate and shape the future of drug discovery. Cyclica Inc., based in Canada, specializes in data-driven drug discovery and artificial intelligence. Valence Labs, also based in Canada, focuses on advancing AI in drug discovery.

Major companies operating in the generative artificial intelligence (AI) in drug discovery market are Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrodinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc

North America was the largest region in the generative AI in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative artificial intelligence (AI) in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative AI in drug discovery market includes revenues earned by entities by providing services such as molecule generation, optimization, virtual screening, predictive modeling, de novo drug design, and consulting support. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative AI in drug discovery market also includes sales of quantum computers, high-performance computing (HPC) clusters, tensor processing units, graphics processing units, and preclinical development tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative Artificial Intelligence (AI) In Drug Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative artificial intelligence (ai) in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative artificial intelligence (ai) in drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative artificial intelligence (ai) in drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Small Molecule; Large Molecule
• 2) By Technology: Deep Learning; Machine Learning; Reinforcement Learning; Molecular Docking; Quantum Computing
• 3) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutions; Contract Research Organizations (CROs); Other End-Users
• Subsegments:
• 1) By Small Molecule: Drug Design And Optimization; Lead Discovery And Identification; Toxicology Prediction; Molecular Property Prediction; ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction
• 2) By Large Molecule: Protein Structure Prediction; Antibody Design; Biologics Optimization; Peptide Design; Biopharmaceutical Discovery And Optimization
• Companies Mentioned: Bayer AG; NVIDIA Corporation; Merck KGaA; IBM Research; Schrodinger Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generative Artificial Intelligence (AI) In Drug Discovery Market Characteristics

3. Generative Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies

4. Generative Artificial Intelligence (AI) In Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Generative Artificial Intelligence (AI) In Drug Discovery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Generative Artificial Intelligence (AI) In Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Growth Rate Analysis
• 5.4. Global Generative Artificial Intelligence (AI) In Drug Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Generative Artificial Intelligence (AI) In Drug Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Generative Artificial Intelligence (AI) In Drug Discovery Total Addressable Market (TAM)

6. Generative Artificial Intelligence (AI) In Drug Discovery Market Segmentation

• 6.1. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule
• Large Molecule
• 6.2. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deep Learning
• Machine Learning
• Reinforcement Learning
• Molecular Docking
• Quantum Computing
• 6.3. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutions
• Contract Research Organizations (CROs)
• Other End-Users
• 6.4. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Design and Optimization
• Lead Discovery and Identification
• Toxicology Prediction
• Molecular Property Prediction
• ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Prediction
• 6.5. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Structure Prediction
• Antibody Design
• Biologics Optimization
• Peptide Design
• Biopharmaceutical Discovery and Optimization

7. Generative Artificial Intelligence (AI) In Drug Discovery Market Regional And Country Analysis

• 7.1. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market

• 8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generative Artificial Intelligence (AI) In Drug Discovery Market

• 9.1. China Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 9.2. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generative Artificial Intelligence (AI) In Drug Discovery Market

• 10.1. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market

• 11.1. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 11.2. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market

• 12.1. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market

• 13.1. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market

• 14.1. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 14.2. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market

• 15.1. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 15.2. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generative Artificial Intelligence (AI) In Drug Discovery Market

• 16.1. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market

• 17.1. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generative Artificial Intelligence (AI) In Drug Discovery Market

• 18.1. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market

• 19.1. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market

• 20.1. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market

• 21.1. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 21.2. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market

• 22.1. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generative Artificial Intelligence (AI) In Drug Discovery Market

• 23.1. North America Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 23.2. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generative Artificial Intelligence (AI) In Drug Discovery Market

• 24.1. USA Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 24.2. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market

• 25.1. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 25.2. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generative Artificial Intelligence (AI) In Drug Discovery Market

• 26.1. South America Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 26.2. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market

• 27.1. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market

• 28.1. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 28.2. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market

• 29.1. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market Overview
• 29.2. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape And Company Profiles

• 30.1. Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape
• 30.2. Generative Artificial Intelligence (AI) In Drug Discovery Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IBM Research Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Generative Artificial Intelligence (AI) In Drug Discovery Market Other Major And Innovative Companies

• 31.1. Valo Health
• 31.2. BenevolentAI
• 31.3. XtalPi Inc.
• 31.4. Insilico Medicine Inc.
• 31.5. Recursion Pharmaceuticals Inc.
• 31.6. Exscientia
• 31.7. Atomwise Inc.
• 31.8. InveniAI LLC
• 31.9. Healx
• 31.10. Aitia
• 31.11. Cloud Pharmaceuticals Inc.
• 31.12. Optibrium
• 31.13. Aiforia
• 31.14. BioSymetrics Inc.
• 31.15. Collaborations Pharmaceuticals Inc.

32. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Drug Discovery Market

34. Recent Developments In The Generative Artificial Intelligence (AI) In Drug Discovery Market

35. Generative Artificial Intelligence (AI) In Drug Discovery Market High Potential Countries, Segments and Strategies

• 35.1 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer